Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bundle of His | 13 | 2022 | 32 | 7.740 |
Why?
|
| Cardiac Pacing, Artificial | 10 | 2022 | 81 | 4.620 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2022 | 149 | 3.350 |
Why?
|
| Cardiac Resynchronization Therapy | 7 | 2021 | 21 | 3.130 |
Why?
|
| Heart Failure | 6 | 2020 | 202 | 3.100 |
Why?
|
| Atrial Fibrillation | 11 | 2023 | 180 | 2.740 |
Why?
|
| Pacemaker, Artificial | 4 | 2022 | 48 | 2.450 |
Why?
|
| Catheter Ablation | 9 | 2022 | 78 | 2.220 |
Why?
|
| Bundle-Branch Block | 4 | 2018 | 16 | 2.010 |
Why?
|
| Electrocardiography | 6 | 2022 | 209 | 1.570 |
Why?
|
| Heart Rate | 6 | 2020 | 142 | 1.560 |
Why?
|
| Heart Ventricles | 6 | 2022 | 170 | 1.540 |
Why?
|
| Action Potentials | 5 | 2020 | 136 | 1.280 |
Why?
|
| Pulmonary Veins | 6 | 2023 | 23 | 1.190 |
Why?
|
| Ventricular Function, Left | 5 | 2020 | 45 | 1.160 |
Why?
|
| Registries | 3 | 2021 | 188 | 1.110 |
Why?
|
| Body Surface Potential Mapping | 2 | 2019 | 7 | 0.850 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 40 | 0.820 |
Why?
|
| Bradycardia | 1 | 2021 | 28 | 0.810 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2020 | 3 | 0.790 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 30 | 0.770 |
Why?
|
| Treatment Outcome | 11 | 2022 | 3478 | 0.750 |
Why?
|
| Humans | 29 | 2023 | 29337 | 0.720 |
Why?
|
| Radiography, Interventional | 1 | 2019 | 24 | 0.680 |
Why?
|
| Dextrocardia | 1 | 2018 | 3 | 0.680 |
Why?
|
| Feasibility Studies | 6 | 2022 | 227 | 0.650 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 29 | 0.630 |
Why?
|
| Time Factors | 7 | 2021 | 1616 | 0.630 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 89 | 0.630 |
Why?
|
| Cryosurgery | 3 | 2020 | 20 | 0.570 |
Why?
|
| Retrospective Studies | 7 | 2022 | 3273 | 0.480 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 556 | 0.480 |
Why?
|
| Aged | 9 | 2022 | 9448 | 0.470 |
Why?
|
| Female | 13 | 2022 | 16197 | 0.460 |
Why?
|
| Middle Aged | 10 | 2022 | 9823 | 0.430 |
Why?
|
| Risk Factors | 5 | 2020 | 2443 | 0.410 |
Why?
|
| Male | 11 | 2022 | 15621 | 0.410 |
Why?
|
| Atrial Appendage | 2 | 2022 | 45 | 0.390 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 4851 | 0.390 |
Why?
|
| Stroke Volume | 2 | 2020 | 56 | 0.360 |
Why?
|
| Diffusion of Innovation | 2 | 2019 | 38 | 0.320 |
Why?
|
| Forecasting | 2 | 2019 | 117 | 0.320 |
Why?
|
| Chicago | 2 | 2020 | 865 | 0.290 |
Why?
|
| Fluoroscopy | 3 | 2020 | 52 | 0.260 |
Why?
|
| Exercise Test | 2 | 2020 | 122 | 0.220 |
Why?
|
| Electrocoagulation | 1 | 2022 | 16 | 0.220 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2019 | 10 | 0.210 |
Why?
|
| Echocardiography | 2 | 2023 | 172 | 0.210 |
Why?
|
| Heart | 2 | 2022 | 91 | 0.210 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 34 | 0.210 |
Why?
|
| Animals | 5 | 2022 | 4552 | 0.200 |
Why?
|
| Atrioventricular Node | 1 | 2020 | 6 | 0.200 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 3 | 0.200 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2020 | 8 | 0.200 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 6 | 0.200 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 33 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 17 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 521 | 0.190 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 175 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2020 | 1811 | 0.180 |
Why?
|
| Pennsylvania | 1 | 2019 | 14 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2020 | 290 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2019 | 7 | 0.170 |
Why?
|
| Radiation Dosage | 1 | 2019 | 31 | 0.170 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 38 | 0.170 |
Why?
|
| London | 1 | 2018 | 3 | 0.170 |
Why?
|
| Hong Kong | 1 | 2018 | 3 | 0.170 |
Why?
|
| Thyroid Diseases | 1 | 2018 | 14 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 40 | 0.170 |
Why?
|
| Amiodarone | 1 | 2018 | 26 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2018 | 27 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 222 | 0.160 |
Why?
|
| Incidence | 1 | 2020 | 756 | 0.160 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 104 | 0.160 |
Why?
|
| Atrioventricular Block | 1 | 2017 | 2 | 0.160 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2017 | 2 | 0.160 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2017 | 11 | 0.160 |
Why?
|
| Heart Block | 1 | 2017 | 19 | 0.160 |
Why?
|
| Disease Progression | 1 | 2020 | 787 | 0.160 |
Why?
|
| Warfarin | 1 | 2018 | 37 | 0.160 |
Why?
|
| Swine | 3 | 2022 | 80 | 0.160 |
Why?
|
| Electric Countershock | 1 | 2017 | 29 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 7 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2017 | 36 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2018 | 100 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2017 | 84 | 0.150 |
Why?
|
| Equipment Design | 3 | 2022 | 185 | 0.140 |
Why?
|
| Exercise | 1 | 2020 | 468 | 0.140 |
Why?
|
| Reoperation | 1 | 2018 | 932 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1830 | 0.110 |
Why?
|
| United States | 1 | 2018 | 2333 | 0.100 |
Why?
|
| Lasers | 2 | 2022 | 16 | 0.100 |
Why?
|
| Therapeutic Irrigation | 2 | 2022 | 66 | 0.100 |
Why?
|
| Recurrence | 2 | 2020 | 350 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2020 | 679 | 0.070 |
Why?
|
| Endocardium | 1 | 2022 | 3 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2022 | 32 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 12 | 0.050 |
Why?
|
| Temperature | 1 | 2021 | 76 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 11 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 12 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 22 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 52 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 42 | 0.050 |
Why?
|
| Alcoholism | 1 | 2020 | 83 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2020 | 159 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 394 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 123 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2018 | 8 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 97 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 266 | 0.040 |
Why?
|
| Ablation Techniques | 1 | 2017 | 3 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 843 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 291 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 840 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 1932 | 0.030 |
Why?
|
| Adult | 1 | 2020 | 8601 | 0.020 |
Why?
|